| Variable | Detected range | Estimated incremental cost ($) | Estimated incremental QALY | Incremental cost-effectiveness ratio ($/QALY) |
| QALY per prevention of 1 case of MTCT | 5~25 | 39,827.83 | 1.32~6.60 | 30,185.10~6,037.02 | Estimated lifetime medical cost of PAH | $250k~$550k | 57,811.19~(−21,356.02) | 5.01 | 11,530.13~(−4,259.34) | HIV prevalence | 0.5%~10% | 40,396.22~36,539.30 | 5.09~4.60 | 7,943.45~7,943.45 | HIV annual cumulative incidence | 0.01%~0.15% | 113,233.84~(−20,316.76) | 0.58~8.65 | 196,399.01~(−2,348.85) | Cost of rapid test | $11.90~$16.32 | 15,661.65~50,341.69 | 5.01 | 3,123.63~10,040.38 | Cost of neonatal prophylaxis | $185~$210 | 39,827.83~40,063.20 | 5.01 | 7,943.45~7,990.39 |
|
|